A multicenter, randomized, double-blind study on the efficacy and safety of Gongxuening capsules in reducing postoperative bleeding after induced abortion

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200005956

Enrollment

Unknown

Registered

2022-05-01

Start date

2022-05-31

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative bleeding after induced abortion

Interventions

Control group:Placebo capsule

Test group:Gongxuening Capsule

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. 20 years old = age = 40 years old; 2. Women with intrauterine pregnancy = 10 weeks and requiring termination of pregnancy without contraindications; 3. Regular menstrual cycle in the past half a year, no recent (half a year) history of induced abortion; 4. The subjects voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to the experimental drugs; 2. Subjects with contraindications to induced abortion; 3. Those with uterine malformation and large uterine fibroids; 4. Those with abnormal coagulation function who are using anticoagulant or hemostatic drugs; 5. Other circumstances judged by the investigator to be inappropriate for inclusion.

Design outcomes

Secondary

Measure	Time frame
Complication;Safety index;Bleeding time;Endometrial repair;Menstrual rehydration time;	—

Primary

Measure	Time frame
Vaginal bleeding volume;	—

Countries

China

Contacts

Public ContactXinyan Liu

lxyhbt20220428@163.com18600008013

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026